ArticleCureus2026
Extraocular Sebaceous Carcinoma of the Scalp in an Elderly Patient.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sebaceous carcinoma (SC) is a rare and aggressive malignant neoplasm of the sebaceous glands, most commonly arising in the periocular region. Extraocular SC, particularly when located on the scalp, is a rare condition that is often misdiagnosed, resulting in delays in treatment. An 85-year-old woman presented to the outpatient clinic with a slowly enlarging scalp mass. Initial surgical excision was performed, and histopathological examination confirmed SC. The patient subsequently underwent wide local excision and comprehensive staging imaging, which revealed no residual disease or metastatic spread. She was therefore managed with close clinical follow-up. Extraocular SC is an aggressive neoplasm with a significant risk of local recurrence and metastasis, particularly when arising on the scalp, where it may be misdiagnosed as other cutaneous malignancies. Accurate diagnosis relies on histopathological evaluation supported by immunohistochemical analysis. Complete surgical excision with clear margins, including wide local excision or Mohs micrographic surgery, remains the cornerstone of treatment. Early recognition and timely intervention are critical determinants of prognosis. SC of the scalp is a rare but potentially life-threatening malignancy. Inclusion of this entity in the differential diagnosis of atypical scalp lesions in elderly patients, along with prompt biopsy and appropriate surgical management, is essential to optimize clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.